Answers are grounded in this paper and cite their sources.
This analysis shows improved post-transplant survival in combined hepatocellular-cholangiocarcinoma, indicating better patient selection methods.
Notably, cHCC-CCA post-LT survival improved from the pre-MMaT-3 to the post-MMaT-3 era. ConclusioncHCC-CCA exhibits favorable waitlist, yet lower long-term post-LT survival compared with HCC and CCA.The improved outcomes observed in the MMaT-3 era suggest that refined selection may have optimized post-LT survival in cHCC-CCA.
No takes yet. Share an insight, caveat, or question.
Sierra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: